• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

Change in findings of culture and sensitivity data if any in chronic otitis media during COVID pandemic

    Raghvendra Singh Gaur, Shammi Kumar Jain, Sanjay Agrawal, Dr. Swati Chandel

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 1067-1073

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Chronic otitis media is an important cause of morbidity affecting all ages leading to variety of complications which has major impact on the patients and more so in Covid pandemic. Study to see the change in findings of culture and sensitivity data in chronic Otitis media during Covid pandemic and hence modify the treatment plan.
Aims: To study the bacteriology associated with the chronic otitis media and study any change in findings of bacteriology of chronic otitis media during COVID pandemic.
Subjects and methods: The retrospective study was done. The culture and sensitivity data during Covid pandemic was collected from Jan 2020 to Jan 2021 from ENT centre and their analysis and interpretation done according to age, types of culture and their sensitivity.
Result: In the total 100 cases of culture and sensitivity results during pandemic, pseudomonas aeruginosa was the most common organism isolated and showed highest sensitivity towards piperacillin/tazobactam and polymyxin B. Staphylococcus aureus was second most common which showed highest sensitivity towards linezolid and teicoplanin. Both showed lowest sensitivity towards ciprofloxacin. There was no change found in the bacteriology culture during the Covid pandemic which was compared from available literature.
Conclusion: the change in the findings of culture and study of chronic otitis media based on the study done shows almost no difference with the pre-pandemic times. But high antibiotic resistance implicates the careful use of antibiotics in treatment and avoiding empirical method of treatment.
Keywords:
    COVID Pandemic CSOM culture sensitivity Pseudomonas
  • PDF (323 K)
  • XML
(2022). Change in findings of culture and sensitivity data if any in chronic otitis media during COVID pandemic. European Journal of Molecular & Clinical Medicine, 9(2), 1067-1073.
Raghvendra Singh Gaur, Shammi Kumar Jain, Sanjay Agrawal, Dr. Swati Chandel. "Change in findings of culture and sensitivity data if any in chronic otitis media during COVID pandemic". European Journal of Molecular & Clinical Medicine, 9, 2, 2022, 1067-1073.
(2022). 'Change in findings of culture and sensitivity data if any in chronic otitis media during COVID pandemic', European Journal of Molecular & Clinical Medicine, 9(2), pp. 1067-1073.
Change in findings of culture and sensitivity data if any in chronic otitis media during COVID pandemic. European Journal of Molecular & Clinical Medicine, 2022; 9(2): 1067-1073.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 69
  • PDF Download: 101
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus